Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
Originally published in Science Express on 24 November 2005
Science 9 December 2005: Vol. 310. no. 5754, pp. 1642 - 1646
DOI: 10.1126/science.1120781
|
|
Research Articles
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Reuben J. Shaw,1,2*
Katja A. Lamia,1,2
Debbie Vasquez,2
Seung-Hoi Koo,3,4
Nabeel Bardeesy,5
Ronald A. DePinho,6
Marc Montminy,3
Lewis C. Cantley1,2
The Peutz-Jegher syndrome tumor-suppressor gene encodes a protein-threonine kinase, LKB1, which phosphorylates and activates AMPK [adenosine monophosphate (AMP)activated protein kinase]. The deletion of LKB1 in the liver of adult mice resulted in a nearly complete loss of AMPK activity. Loss of LKB1 function resulted in hyperglycemia with increased gluconeogenic and lipogenic gene expression. In LKB1-deficient livers, TORC2, a transcriptional coactivator of CREB (cAMP response elementbinding protein), was dephosphorylated and entered the nucleus, driving the expression of peroxisome proliferator-activated receptor-  coactivator 1  (PGC-1  ), which in turn drives gluconeogenesis. Adenoviral small hairpin RNA (shRNA) for TORC2 reduced PGC-1  expression and normalized blood glucose levels in mice with deleted liver LKB1, indicating that TORC2 is a critical target of LKB1/AMPK signals in the regulation of gluconeogenesis. Finally, we show that metformin, one of the most widely prescribed type 2 diabetes therapeutics, requires LKB1 in the liver to lower blood glucose levels.
1 Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
2 Division of Signal Transduction, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.
3 Peptide Biology Laboratories, The Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.
4 Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon 440-746, Korea.
5 Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA.
6 Center for Applied Cancer Science and Department of Medical Oncology, Dana Farber Cancer Institute and Departments of Medicine and Genetics, Harvard Medical School, Boston, MA 02115, USA.
Present address: Molecular and Cell Biology Laboratories, The Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 920371002, USA.
* To whom correspondence should be addressed. E-mail: shaw{at}salk.edu
Read the Full Text
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Central Administration of Resveratrol Improves Diet-Induced Diabetes.
- G. Ramadori, L. Gautron, T. Fujikawa, C. R. Vianna, J. K. Elmquist, and R. Coppari (2009)
Endocrinology
150, 5326-5333
| Abstract »
| Full Text »
| PDF »
- AMPK Regulates the Circadian Clock by Cryptochrome Phosphorylation and Degradation.
- K. A. Lamia, U. M. Sachdeva, L. DiTacchio, E. C. Williams, J. G. Alvarez, D. F. Egan, D. S. Vasquez, H. Juguilon, S. Panda, R. J. Shaw, et al. (2009)
Science
326, 437-440
| Abstract »
| Full Text »
| PDF »
- Homo-oligomerization and Activation of AMP-activated Protein Kinase Are Mediated by the Kinase Domain {alpha}G-Helix.
- R. Scholz, M. Suter, T. Weimann, C. Polge, P. V. Konarev, R. F. Thali, R. D. Tuerk, B. Viollet, T. Wallimann, U. Schlattner, et al. (2009)
J. Biol. Chem.
284, 27425-27437
| Abstract »
| Full Text »
| PDF »
- Metformin improves postprandial glucose homeostasis in rainbow trout fed dietary carbohydrates: a link with the induction of hepatic lipogenic capacities?.
- S. Panserat, S. Skiba-Cassy, I. Seiliez, M. Lansard, E. Plagnes-Juan, C. Vachot, P. Aguirre, L. Larroquet, G. Chavernac, F. Medale, et al. (2009)
Am J Physiol Regulatory Integrative Comp Physiol
297, R707-R715
| Abstract »
| Full Text »
| PDF »
- Tumor Suppression by LKB1: SIK-ness Prevents Metastasis.
- R. J. Shaw (2009)
Science Signaling
2, pe55
| Abstract »
| Full Text »
| PDF »
- Metformin Disrupts Crosstalk between G Protein-Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth.
- K. Kisfalvi, G. Eibl, J. Sinnett-Smith, and E. Rozengurt (2009)
Cancer Res.
69, 6539-6545
| Abstract »
| Full Text »
| PDF »
- Macronutrient Intake and Cancer: How Does Dietary Restriction Influence Tumor Growth and Why Should We Care?.
- M. Pollak (2009)
Cancer Prevention Research
2, 698-701
| Abstract »
| Full Text »
| PDF »
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer.
- S. Jiralerspong, S. L. Palla, S. H. Giordano, F. Meric-Bernstam, C. Liedtke, C. M. Barnett, L. Hsu, M.-C. Hung, G. N. Hortobagyi, and A. M. Gonzalez-Angulo (2009)
J. Clin. Oncol.
27, 3297-3302
| Abstract »
| Full Text »
| PDF »
- mTOR and HIF-1{alpha}-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome.
- D. B. Shackelford, D. S. Vasquez, J. Corbeil, S. Wu, M. Leblanc, C.-L. Wu, D. R. Vera, and R. J. Shaw (2009)
PNAS
106, 11137-11142
| Abstract »
| Full Text »
| PDF »
- LKB1 and AMPK Family Signaling: The Intimate Link Between Cell Polarity and Energy Metabolism.
- M. Jansen, J. P. ten Klooster, G. J. Offerhaus, and H. Clevers (2009)
Physiol Rev
89, 777-798
| Abstract »
| Full Text »
| PDF »
- AMPK in Health and Disease.
- G. R. Steinberg and B. E. Kemp (2009)
Physiol Rev
89, 1025-1078
| Abstract »
| Full Text »
| PDF »
- Identification of the Serine 307 of LKB1 as a Novel Phosphorylation Site Essential for Its Nucleocytoplasmic Transport and Endothelial Cell Angiogenesis.
- Z. Xie, Y. Dong, J. Zhang, R. Scholz, D. Neumann, and M.-H. Zou (2009)
Mol. Cell. Biol.
29, 3582-3596
| Abstract »
| Full Text »
| PDF »
- Effects of 7 days of exercise training on insulin sensitivity and responsiveness in type 2 diabetes mellitus.
- J. P. Kirwan, T. P. J. Solomon, D. M. Wojta, M. A. Staten, and J. O. Holloszy (2009)
Am J Physiol Endocrinol Metab
297, E151-E156
| Abstract »
| Full Text »
| PDF »
- LKB1 regulates polarity remodeling and adherens junction formation in the Drosophila eye.
- N. Amin, A. Khan, D. St. Johnston, I. Tomlinson, S. Martin, J. Brenman, and H. McNeill (2009)
PNAS
106, 8941-8946
| Abstract »
| Full Text »
| PDF »
- Involvement of SIK2/TORC2 signaling cascade in the regulation of insulin-induced PGC-1{alpha} and UCP-1 gene expression in brown adipocytes.
- M. Muraoka, A. Fukushima, S. Viengchareun, M. Lombes, F. Kishi, A. Miyauchi, M. Kanematsu, J. Doi, J. Kajimura, R. Nakai, et al. (2009)
Am J Physiol Endocrinol Metab
296, E1430-E1439
| Abstract »
| Full Text »
| PDF »
- Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase.
- Y. Wang, Y. Huang, K. S.L. Lam, Y. Li, W. T. Wong, H. Ye, C.-W. Lau, P. M. Vanhoutte, and A. Xu (2009)
Cardiovasc Res
82, 484-492
| Abstract »
| Full Text »
| PDF »
- Chemical Genomics Identifies the Unfolded Protein Response as a Target for Selective Cancer Cell Killing during Glucose Deprivation.
- S. Saito, A. Furuno, J. Sakurai, A. Sakamoto, H.-R. Park, K. Shin-ya, T. Tsuruo, and A. Tomida (2009)
Cancer Res.
69, 4225-4234
| Abstract »
| Full Text »
| PDF »
- Hunting for the SNARK in metabolic disease.
- B. Egan and J. R. Zierath (2009)
Am J Physiol Endocrinol Metab
296, E969-E972
| Full Text »
| PDF »
- Energy Homeostasis and Cancer Prevention: The AMP-Activated Protein Kinase.
- J. R. Fay, V. Steele, and J. A. Crowell (2009)
Cancer Prevention Research
2, 301-309
| Abstract »
| Full Text »
| PDF »
- The coactivator CRTC1 promotes cell proliferation and transformation via AP-1.
- G. Canettieri, S. Coni, M. Della Guardia, V. Nocerino, L. Antonucci, L. Di Magno, R. Screaton, I. Screpanti, G. Giannini, and A. Gulino (2009)
PNAS
106, 1445-1450
| Abstract »
| Full Text »
| PDF »
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review.
- S. Palomba, A. Falbo, F. Zullo, and F. Orio Jr. (2009)
Endocr. Rev.
30, 1-50
| Abstract »
| Full Text »
| PDF »
- The molecular mechanisms that underlie the tumor suppressor function of LKB1.
- D. Fan, C. Ma, and H. Zhang (2009)
Acta Biochim Biophys Sin
41, 97-107
| Abstract »
| Full Text »
| PDF »
- Characterization of an Alternative Splice Variant of LKB1.
- F. C. Denison, N. J. Hiscock, D. Carling, and A. Woods (2009)
J. Biol. Chem.
284, 67-76
| Abstract »
| Full Text »
| PDF »
- AMP-activated Protein Kinase Activation Increases Phosphorylation of Glycogen Synthase Kinase 3{beta} and Thereby Reduces cAMP-responsive Element Transcriptional Activity and Phosphoenolpyruvate Carboxykinase C Gene Expression in the Liver.
- N. Horike, H. Sakoda, A. Kushiyama, H. Ono, M. Fujishiro, H. Kamata, K. Nishiyama, Y. Uchijima, Y. Kurihara, H. Kurihara, et al. (2008)
J. Biol. Chem.
283, 33902-33910
| Abstract »
| Full Text »
| PDF »
- Changes in Adenosine 5'-Monophosphate-Activated Protein Kinase as a Mechanism of Visceral Obesity in Cushing's Syndrome.
- B. Kola, M. Christ-Crain, F. Lolli, G. Arnaldi, G. Giacchetti, M. Boscaro, A. B. Grossman, and M. Korbonits (2008)
J. Clin. Endocrinol. Metab.
93, 4969-4973
| Abstract »
| Full Text »
| PDF »
- Maternal overnutrition suppresses the phosphorylation of 5'-AMP-activated protein kinase in liver, but not skeletal muscle, in the fetal and neonatal sheep.
- L. K. Philp, B. S. Muhlhausler, A. Janovska, G. A. Wittert, J. A. Duffield, and I. C. McMillen (2008)
Am J Physiol Regulatory Integrative Comp Physiol
295, R1982-R1990
| Abstract »
| Full Text »
| PDF »
- Lkb1 is required for TGF{beta}-mediated myofibroblast differentiation.
- K. Vaahtomeri, E. Ventela, K. Laajanen, P. Katajisto, P.-J. Wipff, B. Hinz, T. Vallenius, M. Tiainen, and T. P. Makela (2008)
J. Cell Sci.
121, 3531-3540
| Abstract »
| Full Text »
| PDF »
- Activation of TORC1 Transcriptional Coactivator through MEKK1-induced Phosphorylation.
- Y.-T. Siu, Y.-P. Ching, and D.-Y. Jin (2008)
Mol. Biol. Cell
19, 4750-4761
| Abstract »
| Full Text »
| PDF »
- The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase.
- M. Zakikhani, R. J.O. Dowling, N. Sonenberg, and M. N. Pollak (2008)
Cancer Prevention Research
1, 369-375
| Abstract »
| Full Text »
| PDF »
- Incretin-Based Therapies in Type 2 Diabetes Mellitus.
- C. W. Chia and J. M. Egan (2008)
J. Clin. Endocrinol. Metab.
93, 3703-3716
| Abstract »
| Full Text »
| PDF »
- Metformin therapy and clinical uses.
- J. H. Scarpello and H. C. Howlett (2008)
Diabetes and Vascular Disease Research
5, 157-167
| Abstract »
| PDF »
- Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth.
- C. Algire, M. Zakikhani, M.-J. Blouin, J. H. Shuai, and M. Pollak (2008)
Endocr. Relat. Cancer
15, 833-839
| Abstract »
| Full Text »
| PDF »
- Metformin improves endothelial function in normoinsulinemic PCOS patients: a new prospective.
- D. Romualdi, B. Costantini, L. Selvaggi, M. Giuliani, F. Cristello, F. Macri, A. Bompiani, A. Lanzone, and M. Guido (2008)
Hum. Reprod.
23, 2127-2133
| Abstract »
| Full Text »
| PDF »
- Sodium arsenite induces orphan nuclear receptor SHP gene expression via AMP-activated protein kinase to inhibit gluconeogenic enzyme gene expression.
- D. Chanda, S.-J. Kim, I.-K. Lee, M. Shong, and H.-S. Choi (2008)
Am J Physiol Endocrinol Metab
295, E368-E379
| Abstract »
| Full Text »
| PDF »
- Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2.
- D. Jansson, A. C.-H. Ng, A. Fu, C. Depatie, M. Al Azzabi, and R. A. Screaton (2008)
PNAS
105, 10161-10166
| Abstract »
| Full Text »
| PDF »
- SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase.
- X. Hou, S. Xu, K. A. Maitland-Toolan, K. Sato, B. Jiang, Y. Ido, F. Lan, K. Walsh, M. Wierzbicki, T. J. Verbeuren, et al. (2008)
J. Biol. Chem.
283, 20015-20026
| Abstract »
| Full Text »
| PDF »
- Premature aging in mice activates a systemic metabolic response involving autophagy induction.
- G. Marino, A. P. Ugalde, N. Salvador-Montoliu, I. Varela, P. M. Quiros, J. Cadinanos, I. van der Pluijm, J. M.P. Freije, and C. Lopez-Otin (2008)
Hum. Mol. Genet.
17, 2196-2211
| Abstract »
| Full Text »
| PDF »
- Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism.
- W. L. Holland and S. A. Summers (2008)
Endocr. Rev.
29, 381-402
| Abstract »
| Full Text »
| PDF »
- AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome.
- M. Christ-Crain, B. Kola, F. Lolli, C. Fekete, D. Seboek, G. Wittmann, D. Feltrin, S. C. Igreja, S. Ajodha, J. Harvey-White, et al. (2008)
FASEB J
22, 1672-1683
| Abstract »
| Full Text »
| PDF »
- Protein Kinase C{zeta}-dependent LKB1 Serine 428 Phosphorylation Increases LKB1 Nucleus Export and Apoptosis in Endothelial Cells.
- P. Song, Z. Xie, Y. Wu, J. Xu, Y. Dong, and M.-H. Zou (2008)
J. Biol. Chem.
283, 12446-12455
| Abstract »
| Full Text »
| PDF »
- Metformin Treatment for Four Years to Reduce Total and Visceral Fat in Low Birth Weight Girls with Precocious Pubarche.
- L. Ibanez, A. Lopez-Bermejo, M. Diaz, M. V. Marcos, and F. de Zegher (2008)
J. Clin. Endocrinol. Metab.
93, 1841-1845
| Abstract »
| Full Text »
| PDF »
- Pancreatic Lkb1 Deletion Leads to Acinar Polarity Defects and Cystic Neoplasms.
- A. F. Hezel, S. Gurumurthy, Z. Granot, A. Swisa, G. C. Chu, G. Bailey, Y. Dor, N. Bardeesy, and R. A. DePinho (2008)
Mol. Cell. Biol.
28, 2414-2425
| Abstract »
| Full Text »
| PDF »
- Adiponectin, Change in Adiponectin, and Progression to Diabetes in the Diabetes Prevention Program.
- K. J. Mather, T. Funahashi, Y. Matsuzawa, S. Edelstein, G. A. Bray, S. E. Kahn, J. Crandall, S. Marcovina, B. Goldstein, R. Goldberg, et al. (2008)
Diabetes
57, 980-986
| Abstract »
| Full Text »
| PDF »
- STRAD{alpha} Regulates LKB1 Localization by Blocking Access to Importin-{alpha}, and by Association with Crm1 and Exportin-7.
- J. Dorfman and I. G. Macara (2008)
Mol. Biol. Cell
19, 1614-1626
| Abstract »
| Full Text »
| PDF »
- Ovulatory Response to Treatment of Polycystic Ovary Syndrome Is Associated with a Polymorphism in the STK11 Gene.
- R. S. Legro, H. X. Barnhart, W. D. Schlaff, B. R. Carr, M. P. Diamond, S. A. Carson, M. P. Steinkampf, C. Coutifaris, P. G. McGovern, N. A. Cataldo, et al. (2008)
J. Clin. Endocrinol. Metab.
93, 792-800
| Abstract »
| Full Text »
| PDF »
- AMP-activated protein kinase phosphorylates transcription factors of the CREB family.
- D. M. Thomson, S. T. Herway, N. Fillmore, H. Kim, J. D. Brown, J. R. Barrow, and W. W. Winder (2008)
J Appl Physiol
104, 429-438
| Abstract »
| Full Text »
| PDF »
- Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase-Dependent Regulation of the Orphan Nuclear Receptor SHP.
- Y. D. Kim, K.-G. Park, Y.-S. Lee, Y.-Y. Park, D.-K. Kim, B. Nedumaran, W. G. Jang, W.-J. Cho, J. Ha, I.-K. Lee, et al. (2008)
Diabetes
57, 306-314
| Abstract »
| Full Text »
| PDF »
- Phosphatidylinositol Ether Lipid Analogues Induce AMP-Activated Protein Kinase Dependent Death in LKB1-Mutant Non Small Cell Lung Cancer Cells.
- R. M. Memmott, J. J. Gills, M. Hollingshead, M. C. Powers, Z. Chen, B. Kemp, A. Kozikowski, and P. A. Dennis (2008)
Cancer Res.
68, 580-588
| Abstract »
| Full Text »
| PDF »
- LKB1 Deficiency Sensitizes Mice to Carcinogen-Induced Tumorigenesis.
- S. Gurumurthy, A. F. Hezel, J. H. Berger, M. W. Bosenberg, and N. Bardeesy (2008)
Cancer Res.
68, 55-63
| Abstract »
| Full Text »
| PDF »
- Metformin Inhibits Mammalian Target of Rapamycin Dependent Translation Initiation in Breast Cancer Cells.
- R. J.O. Dowling, M. Zakikhani, I. G. Fantus, M. Pollak, and N. Sonenberg (2007)
Cancer Res.
67, 10804-10812
| Abstract »
| Full Text »
| PDF »
- Defining the Mechanism of Activation of AMP-activated Protein Kinase by the Small Molecule A-769662, a Member of the Thienopyridone Family.
- M. J. Sanders, Z. S. Ali, B. D. Hegarty, R. Heath, M. A. Snowden, and D. Carling (2007)
J. Biol. Chem.
282, 32539-32548
| Abstract »
| Full Text »
| PDF »
- Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein Kinase.
- O. Goransson, A. McBride, S. A. Hawley, F. A. Ross, N. Shpiro, M. Foretz, B. Viollet, D. G. Hardie, and K. Sakamoto (2007)
J. Biol. Chem.
282, 32549-32560
| Abstract »
| Full Text »
| PDF »
- Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells.
- C.-L. Lin, H.-C. Huang, and J.-K. Lin (2007)
J. Lipid Res.
48, 2334-2343
| Abstract »
| Full Text »
| PDF »
- A Central Role for Neuronal Adenosine 5'-Monophosphate-Activated Protein Kinase in Cancer-Induced Anorexia.
- E. R. Ropelle, J. R. Pauli, K. G. Zecchin, M. Ueno, C. T. de Souza, J. Morari, M. C. Faria, L. A. Velloso, M. J. A. Saad, and J. B. C. Carvalheira (2007)
Endocrinology
148, 5220-5229
| Abstract »
| Full Text »
| PDF »
- The Energy Sensor AMP-activated Protein Kinase Directly Regulates the Mammalian FOXO3 Transcription Factor.
- E. L. Greer, P. R. Oskoui, M. R. Banko, J. M. Maniar, M. P. Gygi, S. P. Gygi, and A. Brunet (2007)
J. Biol. Chem.
282, 30107-30119
| Abstract »
| Full Text »
| PDF »
- Epigallocatechin-3-gallate (EGCG), A Green Tea Polyphenol, Suppresses Hepatic Gluconeogenesis through 5'-AMP-activated Protein Kinase.
- Q. F. Collins, H.-Y. Liu, J. Pi, Z. Liu, M. J. Quon, and W. Cao (2007)
J. Biol. Chem.
282, 30143-30149
| Abstract »
| Full Text »
| PDF »
- Dialogue Between LKB1 and AMPK: A Hot Topic at the Cellular Pole.
- C. Forcet and M. Billaud (2007)
Sci. STKE
2007, pe51
| Abstract »
| Full Text »
| PDF »
- Metformin -- life begins at 50: A symposium held on the occasion of the 43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam, The Netherlands, September 2007.
- I. W Campbell (2007)
The British Journal of Diabetes & Vascular Disease
7, 247-252
| PDF »
- Insulin, insulin-like growth factors, insulin resistance, and neoplasia.
- M. N Pollak (2007)
Am. J. Clinical Nutrition
86, 820S-821S
| Abstract »
| Full Text »
| PDF »
- Clomiphene Versus Metformin for Ovulation Induction in Polycystic Ovary Syndrome: The Winner Is .....
- R. L. Barbieri (2007)
J. Clin. Endocrinol. Metab.
92, 3399-3401
| Full Text »
| PDF »
- AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1{alpha}.
- S. Jager, C. Handschin, J. St.-Pierre, and B. M. Spiegelman (2007)
PNAS
104, 12017-12022
| Abstract »
| Full Text »
| PDF »
- Systemic Treatment with the Antidiabetic Drug Metformin Selectively Impairs p53-Deficient Tumor Cell Growth.
- M. Buzzai, R. G. Jones, R. K. Amaravadi, J. J. Lum, R. J. DeBerardinis, F. Zhao, B. Viollet, and C. B. Thompson (2007)
Cancer Res.
67, 6745-6752
| Abstract »
| Full Text »
| PDF »
- The Mammalian Target of Rapamycin Pathway as a Potential Target for Cancer Chemoprevention.
- L. Kopelovich, J. R. Fay, C. C. Sigman, and J. A. Crowell (2007)
Cancer Epidemiol. Biomarkers Prev.
16, 1330-1340
| Abstract »
| Full Text »
| PDF »
- Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration.
- L. Zhang, H. He, and J. A. Balschi (2007)
Am J Physiol Heart Circ Physiol
293, H457-H466
| Abstract »
| Full Text »
| PDF »
- Energy Depletion Inhibits Phosphatidylinositol 3-Kinase/Akt Signaling and Induces Apoptosis via AMP-activated Protein Kinase-dependent Phosphorylation of IRS-1 at Ser-794.
- A. Tzatsos and P. N. Tsichlis (2007)
J. Biol. Chem.
282, 18069-18082
| Abstract »
| Full Text »
| PDF »
- TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation.
- A. I. Kuraishy, S. W. French, M. Sherman, M. Herling, D. Jones, R. Wall, and M. A. Teitell (2007)
PNAS
104, 10175-10180
| Abstract »
| Full Text »
| PDF »
- AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells.
- B. J. Krawiec, G. J. Nystrom, R. A. Frost, L. S. Jefferson, and C. H. Lang (2007)
Am J Physiol Endocrinol Metab
292, E1555-E1567
| Abstract »
| Full Text »
| PDF »
- A fundamental system of cellular energy homeostasis regulated by PGC-1{alpha}.
- L. M. Rohas, J. St-Pierre, M. Uldry, S. Jager, C. Handschin, and B. M. Spiegelman (2007)
PNAS
104, 7933-7938
| Abstract »
| Full Text »
| PDF »
- Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivo.
- J. B. Hurov, M. Huang, L. S. White, J. Lennerz, C. S. Choi, Y.-R. Cho, H.-J. Kim, J. L. Prior, D. Piwnica-Worms, L. C. Cantley, et al. (2007)
PNAS
104, 5680-5685
| Abstract »
| Full Text »
| PDF »
- AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling.
- M. C. Towler and D. G. Hardie (2007)
Circ. Res.
100, 328-341
| Abstract »
| Full Text »
| PDF »
- In the regulation of cytochrome P450 genes, phenobarbital targets LKB1 for necessary activation of AMP-activated protein kinase.
- S. M. Blattler, F. Rencurel, M. R. Kaufmann, and U. A. Meyer (2007)
PNAS
104, 1045-1050
| Abstract »
| Full Text »
| PDF »
- Critical role of 5'-AMP-activated protein kinase in the stimulation of glucose transport in response to inhibition of oxidative phosphorylation.
- M. Jing and F. Ismail-Beigi (2007)
Am J Physiol Cell Physiol
292, C477-C487
| Abstract »
| Full Text »
| PDF »
- Statins Activate AMP-Activated Protein Kinase In Vitro and In Vivo.
- W. Sun, T.-S. Lee, M. Zhu, C. Gu, Y. Wang, Y. Zhu, and J. Y-J. Shyy (2006)
Circulation
114, 2655-2662
| Abstract »
| Full Text »
| PDF »
- Metformin increases the PGC-1{alpha} protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo.
- M. Suwa, T. Egashira, H. Nakano, H. Sasaki, and S. Kumagai (2006)
J Appl Physiol
101, 1685-1692
| Abstract »
| Full Text »
| PDF »
- Stimulation of AMP-Activated Protein Kinase Is Essential for the Induction of Drug Metabolizing Enzymes by Phenobarbital in Human and Mouse Liver.
- F. Rencurel, M. Foretz, M. R. Kaufmann, D. Stroka, R. Looser, I. Leclerc, G. da Silva Xavier, G. A. Rutter, B. Viollet, and U. A. Meyer (2006)
Mol. Pharmacol.
70, 1925-1934
| Abstract »
| Full Text »
| PDF »
- Skeletal Muscle-Selective Knockout of LKB1 Increases Insulin Sensitivity, Improves Glucose Homeostasis, and Decreases TRB3.
- H.-J. Koh, D. E. Arnolds, N. Fujii, T. T. Tran, M. J. Rogers, N. Jessen, Y. Li, C. W. Liew, R. C. Ho, M. F. Hirshman, et al. (2006)
Mol. Cell. Biol.
26, 8217-8227
| Abstract »
| Full Text »
| PDF »
- AMP-activated protein kinase and the regulation of glucose transport.
- N. Fujii, N. Jessen, and L. J. Goodyear (2006)
Am J Physiol Endocrinol Metab
291, E867-E877
| Abstract »
| Full Text »
| PDF »
- Metformin Is an AMP Kinase-Dependent Growth Inhibitor for Breast Cancer Cells.
- M. Zakikhani, R. Dowling, I. G. Fantus, N. Sonenberg, and M. Pollak (2006)
Cancer Res.
66, 10269-10273
| Abstract »
| Full Text »
| PDF »
- Effects of Metformin on Microvascular Function and Exercise Tolerance in Women With Angina and Normal Coronary Arteries: A Randomized, Double-Blind, Placebo-Controlled Study.
- S. Jadhav, W. Ferrell, I. A. Greer, J. R. Petrie, S. M. Cobbe, and N. Sattar (2006)
J. Am. Coll. Cardiol.
48, 956-963
| Abstract »
| Full Text »
| PDF »
- Policosanol Inhibits Cholesterol Synthesis in Hepatoma Cells by Activation of AMP-Kinase.
- D. K. Singh, L. Li, and T. D. Porter (2006)
J. Pharmacol. Exp. Ther.
318, 1020-1026
| Abstract »
| Full Text »
| PDF »
- AMP-activated protein kinase underpins hypoxic pulmonary vasoconstriction and carotid body excitation by hypoxia in mammals.
- A. M. Evans (2006)
Exp Physiol
91, 821-827
| Abstract »
| Full Text »
| PDF »
- SNF1-related kinases allow plants to tolerate herbivory by allocating carbon to roots.
- J. Schwachtje, P. E. H. Minchin, S. Jahnke, J. T. van Dongen, U. Schittko, and I. T. Baldwin (2006)
PNAS
103, 12935-12940
| Abstract »
| Full Text »
| PDF »
- Polyphenols Stimulate AMP-Activated Protein Kinase, Lower Lipids, and Inhibit Accelerated Atherosclerosis in Diabetic LDL Receptor-Deficient Mice..
- M. Zang, S. Xu, K. A. Maitland-Toolan, A. Zuccollo, X. Hou, B. Jiang, M. Wierzbicki, T. J. Verbeuren, and R. A. Cohen (2006)
Diabetes
55, 2180-2191
| Abstract »
| Full Text »
| PDF »
- TORC1 and TORC2 Coactivators Are Required for Tax Activation of the Human T-Cell Leukemia Virus Type 1 Long Terminal Repeats.
- Y.-T. Siu, K.-T. Chin, K.-L. Siu, E. Yee Wai Choy, K.-T. Jeang, and D.-Y. Jin (2006)
J. Virol.
80, 7052-7059
| Abstract »
| Full Text »
| PDF »
- AMP-activated protein kinase - development of the energy sensor concept.
- D. G. Hardie, S. A. Hawley, and J. W. Scott (2006)
J. Physiol.
574, 7-15
| Abstract »
| Full Text »
| PDF »
- AMPK and cell proliferation - AMPK as a therapeutic target for atherosclerosis and cancer.
- H. Motoshima, B. J. Goldstein, M. Igata, and E. Araki (2006)
J. Physiol.
574, 63-71
| Abstract »
| Full Text »
| PDF »
- Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders.
- B. Viollet, M. Foretz, B. Guigas, S. Horman, R. Dentin, L. Bertrand, L. Hue, and F. Andreelli (2006)
J. Physiol.
574, 41-53
| Abstract »
| Full Text »
| PDF »
- Developing a head for energy sensing: AMP-activated protein kinase as a multifunctional metabolic sensor in the brain.
- S. Ramamurthy and G. V. Ronnett (2006)
J. Physiol.
574, 85-93
| Abstract »
| Full Text »
| PDF »
- AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues.
- B. Xue and B. B. Kahn (2006)
J. Physiol.
574, 73-83
| Abstract »
| Full Text »
| PDF »
- Emerging Biology of Malignant Salivary Gland Tumors Offers New Insights into the Classification and Treatment of Mucoepidermoid Cancer..
- F. J. Kaye (2006)
Clin. Cancer Res.
12, 3878-3881
| Full Text »
| PDF »
- AMP-activated protein kinase and the regulation of Ca2+ signalling in O2-sensing cells.
- A. M. Evans (2006)
J. Physiol.
574, 113-123
| Abstract »
| Full Text »
| PDF »
- Genetics and biology of pancreatic ductal adenocarcinoma..
- A. F. Hezel, A. C. Kimmelman, B. Z. Stanger, N. Bardeesy, and R. A. DePinho (2006)
Genes & Dev.
20, 1218-1249
| Abstract »
| Full Text »
| PDF »
- Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPK{alpha}2 but not AMPK{alpha}1.
- K. Sakamoto, E. Zarrinpashneh, G. R. Budas, A.-C. Pouleur, A. Dutta, A. R. Prescott, J.-L. Vanoverschelde, A. Ashworth, A. Jovanovic, D. R. Alessi, et al. (2006)
Am J Physiol Endocrinol Metab
290, E780-E788
| Abstract »
| Full Text »
| PDF »
- Glucose-induced repression of PPAR{alpha} gene expression in pancreatic {beta}-cells involves PP2A activation and AMPK inactivation..
- K. Ravnskjaer, M. Boergesen, L. T Dalgaard, and S. Mandrup (2006)
J. Mol. Endocrinol.
36, 289-299
| Abstract »
| Full Text »
| PDF »
- Endocrinology & Metabolism News, January 2006.
- (2006)
J. Clin. Endocrinol. Metab.
91, 17a
| Full Text »
| PDF »
|
|